Micrel (MCRL)

Add to Watchlists
Create an Alert
13.96 -0.04  -0.25% NASDAQ Jul 29, 17:00 Delayed 2m USD

Micrel Research and Development Expense (Quarterly):

13.96M for March 31, 2015

View 4,000+ financial data types

View Full Chart

Micrel Research and Development Expense (Quarterly) Chart

Export Data
Save Image

Micrel Historical Research and Development Expense (Quarterly) Data

View and export this data going back to 1993. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
March 31, 2015 13.96M
Dec. 31, 2014 15.10M
Sept. 30, 2014 16.01M
June 30, 2014 15.44M
March 31, 2014 15.48M
Dec. 31, 2013 14.53M
Sept. 30, 2013 14.06M
June 30, 2013 13.50M
March 31, 2013 13.77M
Dec. 31, 2012 14.60M
Sept. 30, 2012 15.34M
June 30, 2012 13.92M
March 31, 2012 13.32M
Dec. 31, 2011 12.56M
Sept. 30, 2011 12.64M
June 30, 2011 12.23M
March 31, 2011 12.52M
Dec. 31, 2010 11.68M
Sept. 30, 2010 11.68M
June 30, 2010 11.54M
March 31, 2010 11.37M
Dec. 31, 2009 11.14M
Sept. 30, 2009 11.40M
June 30, 2009 11.48M
March 31, 2009 12.49M
Dec. 31, 2008 12.23M
Sept. 30, 2008 13.83M
June 30, 2008 14.76M
March 31, 2008 14.13M
Dec. 31, 2007 13.40M
Sept. 30, 2007 13.68M
June 30, 2007 14.19M
March 31, 2007 13.25M
Dec. 31, 2006 12.81M
Sept. 30, 2006 13.07M
June 30, 2006 13.15M
March 31, 2006 13.04M
Dec. 31, 2005 11.06M
Sept. 30, 2005 11.34M
June 30, 2005 11.25M
March 31, 2005 11.52M
Dec. 31, 2004 10.36M
Sept. 30, 2004 11.14M
June 30, 2004 9.689M
March 31, 2004 10.56M
Dec. 31, 2003 10.63M
Sept. 30, 2003 11.50M
June 30, 2003 12.14M
March 31, 2003 12.69M
Dec. 31, 2002 12.83M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About R&D Expense

R&D expenses are a line item from many companies' income statements.

R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More


MCRL Research and Development Expense (Quarterly) Benchmarks

Microchip Technology 87.66M
NXP Semiconductors 199.00M
Applied Micro Circuits 24.58M

MCRL Research and Development Expense (Quarterly) Range, Past 5 Years

Minimum 11.68M Dec 2010
Maximum 16.01M Sep 2014
Average 13.81M

MCRL Research and Development Expense (Quarterly) Excel Add-In Codes

  • Metric Code: r_and_d_expense
  • Latest data point: =YCP("MCRL", "r_and_d_expense")
  • Last 5 data points: =YCS("MCRL", "r_and_d_expense", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.


You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.


Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.